The endometrium is made up of cells that line the inside of the uterus and the production of abnormal cells in the ...

GSK has claimed US approval for Jemperli alongside chemotherapy for previously untreated, primary advanced or recurrent endometrial cancer, becoming the first immunotherapy option for first-line ...

Generative Phosphoproteomics AP3 platform designed to enable streamlined, rational drug discovery, with proprietary, proteome ...

Acrivon Therapeutics Inc. provided updated phase II data for checkpoint kinase candidate ACR-368, highlighting promising response rates for biomarker-positive patients with endometrial cancer and ...

Acrivon Therapeutics is halting work on developing its lead drug for ovarian and bladder cancers, instead focusing the Eli ...

That’s important for GSK, as Jemperli is currently approved as a first-line therapy for use in endometrial cancer patients whose tumours have mismatch repair deficient (dMMR) or microsatellite ...

The Mayo Clinic and Exact Sciences are developing an easy, noninvasive test to detect endometrial cancer in women with abnormal vaginal bleeding. It analyzes vaginal fluid collected on tampons for ...

The safety and efficacy of dostarlimab plus chemotherapy in patients with advanced endometrial cancer were confirmed by ...

Chemotherapy-based regimens, including in combination with immunotherapy, are a standard first-line therapy for inoperable stage III/IV or recurrent endometrial cancer. Christian Marth ...